Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

NCT07226544 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
31
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

City of Hope Medical Center

Collaborators